GLP-1 agonists address all three pathways mechanistically
BPC-157 is typically reconstituted using sterile bacteriostatic water for multi-dose stability, or sterile water for injection for single-use preparations
Signs that insulin may be needed include persistently elevated blood sugar despite maximum GLP-1 doses, declining endogenous insulin production, and treatment plateaus that suggest the incretin-based approach has reached its limits
Polyglyceryl-2 Triisostearate, Bis-Diglyceryl Polyacyladipate-2, Hydrogenated Polyisobutene, Synthetic Wax, Pentaerythrityl Adipate/Caprate/Caprylate/Heptanoate, Tribehenin, Sorbitan Isostearate, Cetyl Peg/Ppg-10/1 Dimethicone, Bis-Behenyl/Isostearyl/Phytosteryl Dimer Dilinoleyl Dimer Dilinoleate, Limnanthes Alba (Meadowfoam) Seed Oil, Simmondsia Chinensis (Jojoba) Seed Oil, [+/- Titanium Dioxide (CI 77891), Iron Oxides (CI 77491), Iron Oxides (CI 77492), Iron Oxides (CI 77499), Blue 1 Lake (CI 42090), Red 7 Lake (CI 15850), Red 28 Lake (CI 45410), Yellow 5 Lake (CI 19140), Yellow 6 Lake (CI 15985)]